Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
3
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
3
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
allergan
astrazeneca
boston top stories
cancer
clinical trials
deerfield management
europe blog main
europe top stories
gilead sciences
What
bio
roundup
covid
fda
ipo
medicines
acquisitions
activity
announced
approvals
august
biogen
biotech
busy
ceo
clamped
collabs
daniel
days
deal
decisions
delays
developing
devices
drugs
economic
fast
gilead
gilead’s
help
including
introduce
isn’t
legacy
lot
month
new
news
nods
opioid
Language
unset
3
×
Current search:
biogen
×
ipo
×
unset
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More